Antibody screening for red blood cell alloimmunization in patients with chronic kidney disease undergoing hemodialysis in Arak, Iran.
Аннотация
INTRODUCTION
This study aimed to investigate the prevalence of red blood cell (RBC) alloimmunization in hemodialysis-dependent patients with chronic kidney disease (CKD) in Arak, Iran. There is a paucity of incidence data for the region's transfused recipients because pretransfusion antibody screening is not routine.
METHODS
This study investigated the prevalence of RBC alloimmunization among patients with CKD through a cross-sectional analysis from September 2022 to February 2023. A total of 49 transfused patients (33 male and 16 female) with CKD who had received at least 1 unit of ABO- and Rh D-matched RBCs were included. Antibody screening and identification tests were performed on these patients' sera.
RESULTS
The most common blood group among the patients was O Rh D positive (44.9%), followed by A Rh D positive (16.3%), B Rh D positive (14.3%), AB Rh D positive (8.2%), A Rh D negative (6.14%), B Rh D negative (6.1%), and O Rh D negative (4.1%). The mean (SD) number of RBC units transfused was 3.7 (3.3 [range, 1-14]) units; the median (IQR) was 3 (1-6) units. Diabetes was the most common underlying disease (n = 28 [57%]). None of these 49 patients was positive in our analysis for detecting antibodies against transfused RBCs.
DISCUSSION: In this study, none of the patients developed RBC alloantibodies, and more than 50% had diabetes.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.